Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’

R. Soc. open sci. 5, 181457. (Published 1 November 2018). (doi:10.1098/rsos.181457)

This correction refers to an error in figure 6. The key to symbols for (b) was missing. The corrected figure and caption appear below.

Figure 6.

Cell viability of HepG2 cells treated with PLGA-NPs (a), free RSV (b), RSV-PLGA-NPs (a,b) and OA (c). In addition, the group 0 is the control (mean ± s.d., n = 3). *p < 0.05, **p < 0.01.